RxDoctor Payments Data

Karl Hurst-Wicker, MD

Interventional Pain Medicine · Chandler, AZNPI 1962698654

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,543 of the $8,993 with a category attached, or 61.6%. 24 manufacturers reported payments, led by Medtronic at 39.2% of the total. Reporting peaked in 2021 at $2,363 and has fallen 78.2% since, to $516 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.

$8,993in general payments, 2019–2025

Across 205 payments — averaging $43.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Spinal Simplicity, LLC$2K
  • Zavation Medical Products, LLC$1K
  • Nevro Corp.$936
  • Boston Scientific$425
  • Vertiflex, Inc.$199
  • plus $832 from 18 others

What the payments were for

  • Consulting fees$1,00011%
  • Travel & lodging$97311%
  • Food & beverage$5,54362%
  • Education$1,45316%
  • Entertainment$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,993 in reported general payments places this provider in the 50th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$376,810
Medicare patients
425
Services billed
59,626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate13$5,169
Pregabalin79$2,714
Duloxetine Hcl139$2,657
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen68$2,489
Lidocaine12$2,318
Diclofenac Sodium86$1,965
Gabapentin72$1,628
Baclofen60$1,620
Tizanidine Hcl64$1,318
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen120$1,271
Oxycodone Hcl40$1,126
Nortriptyline Hcl35$691
Morphine Sulfate ErMorphine Sulfate26$555
Tramadol Hcl65$483
Celecoxib19$362

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →